Martin F. Crook - Concepedia

Author

Martin F. Crook

National Heart Lung and Blood Institute ORCID

Also Known As

M.F. CROOK, Martin Crook, Martin F Crook, Martin F. Crook

Publications

704

Citations

H-Index

Concepts

All Affiliations

National Heart Lung and Blood Institute Merck & Co., Inc., Rahway, NJ, USA (United States)National Institutes of Health University of Bristol Bristol Royal Infirmary

About

Martin F. Crook is an author at National Heart Lung and Blood Institute specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	321
2	Cell Biology	6	6	243
3	Natural Sciences	3	3	124
4	Biochemistry	3	3	55
5	Health Sciences	1	1	44

Martin F. Crook

Publications

674

Citations

H-Index

Page 1

	Year	Citations
Role of Nuclear Factor-κB Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo Alexander Chase, Mark Bond, Martin F. Crook, Arteriosclerosis Thrombosis and Vascular Biology	2002	166
The arginine methyltransferase PRMT2 binds RB and regulates E2F function Takanobu Yoshimoto, Manfred Boehm, Michelle Olive, Experimental Cell Research ChromatinTranscriptional RegulationChromatin StructureMolecular RegulationNatural Sciences	2006	86
Disruption of Protein Arginine <i>N</i> -Methyltransferase 2 Regulates Leptin Signaling and Produces Leanness In Vivo Through Loss of STAT3 Methylation Hiroaki Iwasaki, Jason C. Kovacic, Michelle Olive, Circulation Research	2010	79
Bone marrow–derived immune cells regulate vascular disease through a p27Kip1-dependent mechanism Manfred Boehm, Michelle Olive, Andrea L. True, Journal of Clinical Investigation	2004	54
Bone marrow–derived immune cells regulate vascular disease through a p27Kip1-dependent mechanism Manfred Boehm, Michelle Olive, Andrea L. True, Journal of Clinical Investigation	2004	54
Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture Martin F. Crook, Andrew C. Newby, Kay M. Southgate Atherosclerosis InflammationInflammatory CytokinesAngiogenesisHuman Saphenous VeinsCell Adhesion	2000	45
KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice Thomas Langenickel, Michelle Olive, Manfred Boehm, Journal of Clinical Investigation CytoskeletonCellular PhysiologyCardiovascular Translational ResearchAngiogenesisCell Regulation	2008	44
Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series Jason M. Cox, Hong D. Chu, Christine Yang, Bioorganic & Medicinal Chemistry Letters Heterocyclic Amide ReplacementsOxazolidinedione SeriesBiochemistryMedicineMechanism Of Action	2014	26
The cell cycle regulator p27<sup>Kip1</sup> interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication Shriram Nallamshetty, Martin F. Crook, Manfred Boehm, FEBS Letters ChromatinTranscriptional RegulationGenome InstabilityCell RegulationCell Division	2005	25
GA‐binding protein regulates KIS gene expression, cell migration, and cell cycle progression Martin F. Crook, Michelle Olive, Hai‐Hui Xue, The FASEB Journal Cell CycleCellular PhysiologyTranscriptional RegulationSignaling PathwayCell Regulation	2007	24

Page 1